Skip to main navigation Skip to search Skip to main content

Bringing Radiotracing to Titanium-Based Antineoplastics: Solid Phase Radiosynthesis, PET and ex Vivo Evaluation of Antitumor Agent [(45)Ti](salan)Ti(dipic)

Gregory Severin, Carsten H Nielsen, Andreas I Jensen, Jesper Fonslet, Andreas Kjær, Fedor Zhuravlev

43 Citations (Scopus)

Abstract

We present a novel solid-phase based (45)Ti radiolabeling methodology and the implementation of (45)Ti-PET in titanium-based antineoplastics using the showcase compound [(45)Ti](salan)Ti(dipic). This development is intended to allow elucidation of the biodistribution and pharmacokinetics of promising new Ti-based therapeutics.

Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume58
Issue number18
Pages (from-to)7591-5
Number of pages5
ISSN0022-2623
DOIs
Publication statusPublished - 24 Sept 2015

Keywords

  • Animals
  • Antineoplastic Agents
  • Coordination Complexes
  • HT29 Cells
  • Humans
  • Mice, Nude
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Solid-Phase Synthesis Techniques
  • Tissue Distribution
  • Titanium
  • Xenograft Model Antitumor Assays

Fingerprint

Dive into the research topics of 'Bringing Radiotracing to Titanium-Based Antineoplastics: Solid Phase Radiosynthesis, PET and ex Vivo Evaluation of Antitumor Agent [(45)Ti](salan)Ti(dipic)'. Together they form a unique fingerprint.

Cite this